Your Article Summary
A systematic review of the cardiovascular risk of inhaled anticholinergics in patients with COPD
International Journal of COPD, 07/01/09
Hilleman DE et al. - The long-term use of inhaled anticholinergic agents has recently been suggested to be associated with an excess risk of adverse cardiovascular (CV) outcomes in patients with COPD. The relative risks for serious CV events, heart failure, and myocardial infarction were all significantly lower with tiotropium than placebo.
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Novel Therapies for Pemphigus Vulgaris: An Overview
Drugs & Aging, 09/21/09
Antithrombotic medication for stroke prevention
Expert Review of Cardiovascular Therapy , 10/20/09
Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia
Annals of Internal Medicine, 11/03/09

See Latest Articles